ALGN · Align Technology, Inc.
$170.602026-05-17Sector: Healthcare; Industry: Medical - Devices; Sub-Industry: Health Care Supplies
Intrinsic Value Range Comparison · Mulya.ai
R&D capitalized (5yr)Base · active
$156
-8.7% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($141 · $214) Analysts Range ($140 · $220) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2021.Q4 | $4.0B | — | 29.9% | 23.7% | $902MM | −$225MM | $677MM | 12.3% | — | 28.4% | $3.2B | $10.76 | — |
| 2022.Q4 | $3.7B | -5.5% | 20.9% | 39.6% | $470MM | −$371MM | $99MM | 12.2% | — | 14.1% | $3.5B | $5.04 | — |
| 2023.Q4 | $3.9B | 3.4% | 20.2% | 30.6% | $541MM | −$153MM | $389MM | 11.7% | — | 15.1% | $3.7B | $6.20 | — |
| 2024.Q4 | $4.0B | 3.5% | 18.4% | 30.8% | $510MM | −$341MM | $168MM | 12.3% | — | 13.5% | $3.9B | $5.87 | — |
| 2025.Q4 | $4.0B | 0.9% | 16.5% | 29.9% | $467MM | −$315MM | $152MM | 12.6% | — | 11.8% | $4.0B | $5.72 | 18.4 |
| italics below = DCF projection · 10yr Rev CAGR: 4.7% |
| 2026.Q4 | $4.2B | +3.8% | 18.6% | 28.9% | $553MM | −$391MM | $162MM | 10.3% | $147MM | 13.1% | $4.4B | $6.36 | 26.8 |
| 2027.Q4 | $4.4B | +4.5% | 19.0% | 27.9% | $601MM | −$317MM | $283MM | 10.2% | $233MM | 13.1% | $4.7B | $6.91 | 24.7 |
| 2028.Q4 | $4.6B | +5.8% | 20.4% | 26.9% | $692MM | −$318MM | $374MM | 10.0% | $279MM | 14.1% | $5.1B | $7.96 | 21.4 |
| 2029.Q4 | $4.9B | +5.7% | 20.4% | 25.9% | $741MM | −$404MM | $337MM | 9.8% | $229MM | 14.1% | $5.5B | $8.52 | 20.0 |
| 2030.Q4 | $5.1B | +5.0% | 20.4% | 24.9% | $788MM | −$354MM | $434MM | 9.7% | $270MM | 14.0% | $5.8B | $9.06 | 18.8 |
|
| Term. Yr+ | $6.6B | 4.1% | 19.9% | 20.0% | $1.1B | −$331MM | $727MM | 8.6% | $6.5B | 13.1% | — | — | — |
Active scenario IV: $156 (-8.7% vs market)